Corporate Governance

Eurofins aspires to the highest standards of corporate governance as part of its vision to be the world leader in bioanalytical testing. Inspiring leadership and efficient organisational structures and systems should enable it to reach this goal and also provide shareholders with additional comfort as well as high returns on investment. Eurofins is committed to conducting business in a responsible and ethical way and has therefore adopted a Group Code of Ethics.

Eurofins currently uses as a best practice reference the corporate governance guidelines as set out in the AFEP/MEDEF recommendations (which can be found via the following web link: http://www.medef.com/medef-corporate/publications.html). As a company registered and listed in France, Eurofins is also regulated by the AMF and NYSE Euronext.

The Company believes that a principles-based approach allows it to continue to be entrepreneurial at the same time as looking after shareholders interests. Indeed these two concepts should complement rather than compromise each other. The Board of Directors (“Conseil d’Administration”) also believes that a company with a good approach to corporate governance is a sign of a well-managed company.

The Board of Directors considers that the current corporate governance environment at Eurofins is appropriate for a business of its size, nature and operations.

During the year the Company continues to make efforts to improve its overall standards of governance.

The Group is run on a day-to-day basis by the Group Executive Committee (Management Board).